RSF Bio is interested in speaking with potential partners to license, develop, fund, and commercialize its technology and products on a country-by-country, or worldwide, basis.
RSF Bio is interested in talking with angel investors, venture capitalists, and other persons and individuals about participating in the company’s various financing rounds.
RSF Bio is interested in speaking with potential collaborators regarding the further development and commercialization of Ataciguat for CAVS.
RSF Bio is also seeking opportunities to partner license, or acquire, products or technologies to complement RSF Bio’s current developments.
RSF Bio is interested in speaking with companies who are interested in any other mergers and acquisition activity involving the company.
Copyright © 2021 RSF Bio - All Rights Reserved.